Wednesday, December 23, 2020 5:41:22 PM
Todd Violette
Todd Violette is an expert in strategic development of emerging companies and was an active member of the Board of Directors of a NASDAQ Listed Bioscience company based in Israel and CFO of a private Pharma Extraction Company based in Madisonville, Kentucky. He has spent years researching and talking to management teams about effective strategies regarding capital formations and achieving cash flow. Todd’s unique view comes from a combination of being an investor and operating businesses. He has previously operated an 85,000 sq. ft. facility with over 150 staff members handling orders for Nike, and a subcontractor to a NFL and NBA licensor which required drop shipping to over 5,500 locations. Mr. Violette, since graduating University in 1992, has been in the financial industry working for banks, broker dealers and being an independent investor with his own capital. Mr. Violette graduated from the University of Maryland College Park in 1992 and is a member of Sigma Chi Fraternity.
https://esgcapitalinc.com/board-of-directors-and-management/#management
Recent APYP News
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 05/17/2024 12:20:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 12:15:19 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 08:00:10 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/26/2024 04:13:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 02/14/2024 02:29:42 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 02/08/2024 08:13:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/16/2023 05:24:36 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/13/2023 11:29:06 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:43:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/03/2023 12:53:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/28/2023 08:47:30 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/28/2023 08:46:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:05:20 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM